The 4th Study Session hosted by the Intestinal Flora Transplantation Clinical Study Group was held
On Sunday, March 17, 2018, a study session was hosted by the Intestinal Flora Transplantation Clinical Study Group.
Doctors from affiliated medical institutions from all over Japan participated in a lively exchange of ideas.
New participants this time were Dr. Kitamura, Director of Kitamura Clinic in Onojo City, Fukuoka Prefecture (an affiliated medical institution for intestinal flora transplantation), and Dr. Koike, a specialist in nutritional therapy, from Tokyo.
Mr. Makoto Shimizu (Symbiosis LLC), Director Kitamura (Kitamura Clinic)
Study Session
Reception
The patent application was completed at the end of February, allowing us to clearly state the specificity of the intestinal flora transplantation of our research group.
We will continue to utilize this technology and work to have it recognized as a medical treatment that can contribute to the health of even more people.
Please look forward to the development of intestinal flora transplantation.
その他の Notices and Activity Reports に関する記事
Articles about other Notices and Activity Reports
April 03, 2024
【Event】 Dr. Shirotani will speak at the 7th Annual Conference of the Japanese Society of Preemptive Clinical Medicine
Dr. Masahiko Shirotani, Executive Director of the Luke’s Ashiya Clinic, will deliver a special lecture at the 7th Annual Conference of the Japanese Society of Preemptive Medicine to be held on June 22 (Sat.) and 23 (Sun.), 2024. Dr. Zen Tanaka, President of Tanaka Clinic, Nizenkai Medical Corporation, will be the chairperson. Lecture Contents Special […]
March 04, 2024
〈Registration Start〉8th Annual Conference
We are pleased to announce that the 8th Annual Conference will be held again this year. (Venue and online)Anyone is welcome to attend, not only healthcare professionals, but also the general public, students, etc. Date and Time Sunday, September 22, 2024Start 11:00 am (Registration 10:30 am) – Closing at 5:00 pm *General Meeting: Held before […]
February 04, 2024
Interview with Goro Tsukamoto at the 7th Annual Meeting
‘Gut Flora Transplantation Clinical Study Group of Experts〜Aiming for easier access to treatment, we are challenging research and development.Pharmacist, Doctor of Engineering Goro Tsukamoto: Former Director and General Manager of Drug Discovery Research Institute, Bell Boss, Former Visiting Professor, University of Pittsburgh, USA, Former Professor, Nagaoka University of Technology The world’s first migraine drug, invented […]
